AAAAAA
Results:
1-22
|
Results: 22
Authors:
BACK D
BRECKENRIDGE A
Citation: D. Back et A. Breckenridge, UNTITLED, British journal of clinical pharmacology, 45(2), 1998, pp. 93-93
Authors:
MULCAHY F
BARRY M
MERRY C
BACK D
Citation: F. Mulcahy et al., NELFINAVIR AND NEVIRAPINE INTERACTION, AIDS, 12(17), 1998, pp. 2361-2361
Authors:
BARRY M
GIBBONS S
BACK D
MULCAHY F
Citation: M. Barry et al., PROTEASE INHIBITORS IN PATIENTS WITH HIV DISEASE - CLINICALLY IMPORTANT PHARMACOKINETIC CONSIDERATIONS, Clinical pharmacokinetics, 32(3), 1997, pp. 194-209
Authors:
MERRY C
MULCAHY F
BARRY M
GIBBONS S
BACK D
Citation: C. Merry et al., SAQUINAVIR INTERACTION WITH MIDAZOLAM - PHARMACOKINETIC CONSIDERATIONS WHEN PRESCRIBING PROTEASE INHIBITORS FOR PATIENTS WITH HIV DISEASE, AIDS, 11(2), 1997, pp. 268-269
Authors:
BLOEMENKAMP K
HELMERHORST F
JESPERSEN J
KLUFT C
SKOUBY S
HANNAFORD P
NORRIS L
ARCHER D
LIDEGAARD O
LUBSEN K
ROSENDAAL F
THOROGOOD M
VANDENBROUCKE J
BACK D
BRAKMAN O
FOTHERBY K
LEUVEN JG
HAMERLYNCK J
KUHL H
SAMSIOE G
Citation: K. Bloemenkamp et al., CONSENSUS DEVELOPMENT MEETING 1995 - COMBINED ORAL-CONTRACEPTIVES ANDCARDIOVASCULAR-DISEASE - THE CONSENSUS STATEMENT ISSUED AFTER THE 2NDEUROPEAN CONFERENCE ON SEX STEROIDS AND METABOLISM, AMSTERDAM, NOVEMBER 1995, Gynecological endocrinology, 10(1), 1996, pp. 1-5
Authors:
MERRY C
BARRY M
GIBBONS S
MULCAHY F
BACK D
Citation: C. Merry et al., IMPROVED TOLERABILITY OF RITONAVIR DERIVED FROM PHARMACOKINETIC PRINCIPLES, British journal of clinical pharmacology, 42(6), 1996, pp. 787-787
Authors:
MERRY C
MULCAHY F
GIBBONS S
LLOYD J
BARRY M
BACK D
Citation: C. Merry et al., ALPHA(1)-ACID GLYCOPROTEIN CONCENTRATION IN HIV DISEASE - IMPLICATIONS FOR TREATMENT WITH PROTEASE INHIBITORS, AIDS, 10, 1996, pp. 21-21
Authors:
MERRY C
RYAN M
MULCAHY F
HEAVEY J
GIBBONS S
BARRY M
BACK D
Citation: C. Merry et al., TOLERABILITY OF RITONAVIR AND SAQUINAVIR DURING TRIPLE THERAPY FOR HIV-INFECTION, AIDS, 10, 1996, pp. 22-22
Authors:
BACK D
VEAL G
KHOO S
BARRY M
Citation: D. Back et al., IN-VITRO ACTIVATION OF NUCLEOSIDE ANALOG DRUGS USED IN COMBINATION INTHE MRC QUATTRO TRIAL, AIDS, 10, 1996, pp. 27-27
Authors:
PHIBOONBANAKIT D
KHOO S
WATANAGOON Y
NABANGCHANG K
HOGGARD P
GIBBONS S
BARRY M
BACK D
Citation: D. Phiboonbanakit et al., ZIDOVUDINE PHOSPHORYLATION IN HIV-INFECTED THAI PATIENTS, AIDS, 10, 1996, pp. 28-28
Authors:
MERRY C
BARRY M
MULCAHY F
HEAVEY J
TJIA J
GIBBONS S
BACK D
Citation: C. Merry et al., SAQUINAVIR PHARMACOKINETICS ALONE AND IN COMBINATION WITH RITONAVIR IN PATIENTS WITH HIV DISEASE, AIDS, 10, 1996, pp. 61-61
Authors:
KAPEMBWA MS
FLEMING SC
ORR M
WELLS C
BLAND M
BACK D
GRIFFIN GE
Citation: Ms. Kapembwa et al., IMPAIRED ABSORPTION OF ZIDOVUDINE IN PATIENTS WITH AIDS-RELATED SMALL-INTESTINAL DISEASE, AIDS, 10(13), 1996, pp. 1509-1514
Authors:
HOGGARD P
KHOO S
BARRY M
BACK D
Citation: P. Hoggard et al., INTRACELLULAR METABOLISM OF ZIDOVUDINE AND STAVUDINE IN COMBINATION, The Journal of infectious diseases, 174(3), 1996, pp. 671-672
TECHNICAL BASIS FOR EPAS PROPOSED REGULATION ON THE CLEANUP OF SITES CONTAMINATED WITH RADIOACTIVITY
Authors:
WOLBARST AB
MAURO J
ANIGSTEIN R
BACK D
BARTLETT JW
BERES D
CHAN D
CLARK ME
DOEHNERT M
DURMAN E
HAY S
HULL HB
LAILAS N
MACKINNEY J
RALSTON L
TSIRIGOTIS PL
Citation: Ab. Wolbarst et al., TECHNICAL BASIS FOR EPAS PROPOSED REGULATION ON THE CLEANUP OF SITES CONTAMINATED WITH RADIOACTIVITY, Health physics, 71(5), 1996, pp. 644-660
Authors:
GIBB D
BARRY M
ORMESHER S
NOKES L
SEEFRIED M
GIAQUINTO C
BACK D
Citation: D. Gibb et al., PHARMACOKINETICS OF ZIDOVUDINE AND DIDEOXYINOSINE ALONE AND IN COMBINATION IN CHILDREN WITH HIV-INFECTION, British journal of clinical pharmacology, 39(5), 1995, pp. 527-530
Authors:
OPELZ G
WUJCIAK T
BACK D
MYTILINEOS J
SCHWARZ V
ALBRECHT G
Citation: G. Opelz et al., INFLUENCE OF HLA COMPATIBILITY ON KIDNEY- TRANSPLANTATION, Infusionstherapie und Transfusionsmedizin, 21(3), 1994, pp. 198-202
Authors:
BARRY M
WILD M
VEAL G
BACK D
BRECKENRIDGE A
FOX R
BEECHING N
NYE F
CAREY P
TIMMINS D
Citation: M. Barry et al., ZIDOVUDINE PHOSPHORYLATION IN HIV-INFECTED PATIENTS AND SERONEGATIVE VOLUNTEERS, AIDS, 8(8), 1994, pp. 60000001-60000005
Authors:
BRENNER B
BACK D
BENPORATH E
HAZANI A
MARTINOWITZ U
TATARSKY I
Citation: B. Brenner et al., COINFECTION WITH HEPATITIS VIRUSES AND HUMAN-IMMUNODEFICIENCY-VIRUS IN MULTIPLY TRANSFUSED PATIENTS, Israel journal of medical sciences, 30(12), 1994, pp. 886-890
Authors:
BARRY M
HOWE J
BACK D
BRECKENRIDGE A
BRETTLE R
MITCHELL R
BEECHING NJ
NYE FJ
Citation: M. Barry et al., THE EFFECTS OF INDOMETHACIN AND NAPROXEN ON ZIDOVUDINE PHARMACOKINETICS, British journal of clinical pharmacology, 36(1), 1993, pp. 82-85
Authors:
BARRY M
BACK D
ORMESHER S
BEECHING N
NYE F
Citation: M. Barry et al., METABOLISM OF DIDANOSINE (DDI) BY ERYTHROCYTES - PHARMACOKINETIC IMPLICATIONS, British journal of clinical pharmacology, 36(1), 1993, pp. 87-88
Authors:
BENNAHMIAS M
BELLO AF
BACK D
RADOUSKY HB
GOODWIN TJ
KLAVINS P
SHELTON RN
Citation: M. Bennahmias et al., MAGNETIC-PROPERTIES OF POLYCRYSTALLINE R1.5CE0.5SR2CU2NBO10 (R=EU, ND, AND SM) HIGH-T(C) SUPERCONDUCTING CERAMICS, Physical review. B, Condensed matter, 48(9), 1993, pp. 6525-6532
Authors:
OPELZ G
WUJCIAK T
SCHWARZ V
BACK D
MYTILINEOS J
SCHERER S
Citation: G. Opelz et al., COLLABORATIVE TRANSPLANT STUDY ANALYSIS OF GRAFT-SURVIVAL IN BLACKS, Transplantation proceedings, 25(4), 1993, pp. 2443-2445
Risultati:
1-22
|